ArticleLeukemia2013

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.

S Goldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.